Prescription Trends of Hydrochlorothiazide vs. Chlorthalidone in the United States (2019-2024).

Saved in:
Bibliographic Details
Title: Prescription Trends of Hydrochlorothiazide vs. Chlorthalidone in the United States (2019-2024).
Authors: Asante R; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Yao Z; Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD, United States., Dzaye O; Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD, United States.; Division of Vascular and Interventional Radiology, Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Berning P; Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD, United States.; Division of Vascular and Interventional Radiology, Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Jelwan Y; Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD, United States., Burka S; Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD, United States., Blumenthal RS; Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD, United States., Blaha MJ; Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD, United States.
Source: American journal of hypertension [Am J Hypertens] 2026 Mar 01; Vol. 39 (3), pp. 459-465.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 8803676 Publication Model: Print Cited Medium: Internet ISSN: 1941-7225 (Electronic) Linking ISSN: 08957061 NLM ISO Abbreviation: Am J Hypertens Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1941-7225
DOI:10.1093/ajh/hpaf190